PCM
TDOC icon

Peregrine Capital Management’s Teladoc Health TDOC Stock Holding History

Peregrine Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,160
Closed -$29K – 331
2022
Q3 		$29K Hold
1,160
– – ﹤0.01% 288
2022
Q2 		$39K Hold
1,160
– – ﹤0.01% 291
2022
Q1 		$84K Sell
1,160
-465,828
-100% -$33.6M ﹤0.01% 293
2021
Q4 		$42.9M Buy
466,988
+96,808
+26% +$11.6M 0.86% 24
2021
Q3 		$46.9M Buy
370,180
+55,447
+18% +$8.07M 0.97% 23
2021
Q2 		$52.3M Buy
314,733
+116,274
+59% +$18.8M 0.94% 19
2021
Q1 		$36.1M Buy
198,459
+13,877
+8% +$3.22M 0.67% 27
2020
Q4 		$36.9M Buy
184,582
+15,358
+9% +$3.12M 0.7% 29
2020
Q3 		$37.1M Sell
169,224
-93,358
-36% -$19.8M 0.98% 17
2020
Q2 		$50.1M Sell
262,582
-22,617
-8% -$3.96M 1.42% 2
2020
Q1 		$44.2M Sell
285,199
-286,830
-50% -$33.4M 1.58% 2
2019
Q4 		$47.9M Sell
572,029
-2,978
-0.5% -$227K 1.22% 3
2019
Q3 		$38.9M Buy
575,007
+164,501
+40% +$10.8M 1.06% 4
2019
Q2 		$27.3M Buy
410,506
+52,868
+15% +$3.08M 0.67% 38
2019
Q1 		$19.9M Sell
357,638
-11,185
-3% -$683K 0.5% 77
2018
Q4 		$18.3M Buy
368,823
+55,825
+18% +$3.42M 0.52% 70
2018
Q3 		$27M Sell
312,998
-62,764
-17% -$4.47M 0.64% 50
2018
Q2 		$21.8M Sell
375,762
-175,962
-32% -$8.59M 0.54% 68
2018
Q1 		$22.2M Sell
551,724
-97,140
-15% -$3.67M 0.54% 61
2017
Q4 		$22.6M Sell
648,864
-9,059
-1% -$301K 0.53% 60
2017
Q3 		$21.8M Buy
657,923
+9,462
+1% +$310K 0.52% 65
2017
Q2 		$22.5M Sell
648,461
-254,923
-28% -$7.43M 0.56% 59
2017
Q1 		$22.5M Buy
903,384
+175,158
+24% +$3.64M 0.57% 57
2016
Q4 		$12M Buy
728,226
+12,420
+2% +$211K 0.31% 128
2016
Q3 		$13.1M Buy
+715,806
New +$12.6M 0.34% 123

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Peregrine Capital Management's TDOC Position: Q4 2022 in Review

Peregrine Capital Management sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 1,160 shares — an estimated $29K sold.

Peregrine Capital Management first reported a position in TDOC in Q3 2016 and held it in 25 quarters. The position peaked at $52.3M in Q2 2021. 445 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Peregrine Capital Management reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Peregrine Capital Management sold 1,160 Teladoc Health shares in Q4 2022, an estimated $29K.
  • Peregrine Capital Management first reported a position in Teladoc Health in Q3 2016 and held it in 25 quarters.
  • Peregrine Capital Management's Teladoc Health position peaked at $52.3M in Q2 2021.
  • 445 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Peregrine Capital Management's 13F filing for Q4 2022, filed 10 Jan 2023.